MPS Loria Financial Planners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-3,924
| Closed | -$260K | – | 73 |
|
2022
Q1 | $260K | Buy |
3,924
+14
| +0.4% | +$928 | 0.11% | 68 |
|
2021
Q4 | $227K | Sell |
3,910
-692
| -15% | -$40.2K | 0.09% | 76 |
|
2021
Q3 | $276K | Buy |
4,602
+51
| +1% | +$3.06K | 0.13% | 65 |
|
2021
Q2 | $273K | Sell |
4,551
-795
| -15% | -$47.7K | 0.13% | 62 |
|
2021
Q1 | $265K | Sell |
5,346
-382
| -7% | -$18.9K | 0.12% | 63 |
|
2020
Q4 | $289K | Sell |
5,728
-100
| -2% | -$5.05K | 0.13% | 58 |
|
2020
Q3 | $319K | Sell |
5,828
-1
| -0% | -$55 | 0.17% | 46 |
|
2020
Q2 | $308K | Sell |
5,829
-2,306
| -28% | -$122K | 0.16% | 46 |
|
2020
Q1 | $363K | Sell |
8,135
-348
| -4% | -$15.5K | 0.28% | 33 |
|
2019
Q4 | $422K | Hold |
8,483
| – | – | 0.25% | 35 |
|
2019
Q3 | $378K | Sell |
8,483
-37
| -0.4% | -$1.65K | 0.25% | 37 |
|
2019
Q2 | $351K | Sell |
8,520
-307
| -3% | -$12.6K | 0.22% | 42 |
|
2019
Q1 | $357K | Buy |
8,827
+69
| +0.8% | +$2.79K | 0.24% | 42 |
|
2018
Q4 | $332K | Buy |
8,758
+51
| +0.6% | +$1.93K | 0.24% | 45 |
|
2018
Q3 | $345K | Sell |
8,707
-107
| -1% | -$4.24K | 0.22% | 46 |
|
2018
Q2 | $309K | Hold |
8,814
| – | – | 0.31% | 49 |
|
2018
Q1 | $308K | Buy |
8,814
+110
| +1% | +$3.84K | 0.22% | 51 |
|
2017
Q4 | $302K | Hold |
8,704
| – | – | 0.21% | 56 |
|
2017
Q3 | $295K | Buy |
8,704
+88
| +1% | +$2.98K | 0.21% | 55 |
|
2017
Q2 | $250K | Buy |
+8,616
| New | +$250K | 0.17% | 58 |
|